COVID-19 Impact on Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-infectious-disease-point-of-care-diagnostics-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Abbott
- Siemens
- GE Healthcare
- Accriva
- Terumo
- BioMerieux
- Diasorin
- Roche
- Danaher Corporation
- BD
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Diaxonhit
- Eiken Chemical
- EMD Millipore
- Epitope Diagnostic
- Euroimmun
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
- Over-the-counter (OTC) Testing Kits
- Prescription-based Testing Kits
- Bacterial Infections
- Fungal Infection
- Virus Infection
- Cardiovascular Infection
- Gastrointestinal Infection
- Sexually Transmitted Disease (STD) Infection
- Central Nervous System Infection
- Other
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players.
- To present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
1.4 Market Analysis by Type
1.4.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Over-the-counter (OTC) Testing Kits
1.4.3 Prescription-based Testing Kits
1.5 Market by Application
1.5.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Bacterial Infections
1.5.3 Fungal Infection
1.5.4 Virus Infection
1.5.5 Cardiovascular Infection
1.5.6 Gastrointestinal Infection
1.5.7 Sexually Transmitted Disease (STD) Infection
1.5.8 Central Nervous System Infection
1.5.9 Other
1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Point of Care Diagnostics Industry Impact
1.6.1 How the Covid-19 is Affecting the Infectious Disease Point of Care Diagnostics Industry
1.6.1.1 Infectious Disease Point of Care Diagnostics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Infectious Disease Point of Care Diagnostics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Infectious Disease Point of Care Diagnostics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Infectious Disease Point of Care Diagnostics Market Perspective (2015-2026)
2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions
2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infectious Disease Point of Care Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Infectious Disease Point of Care Diagnostics Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Market Size
3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
3.2.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2019
3.3 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
3.4 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
3.5 Date of Enter into Infectious Disease Point of Care Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2021-2026)
5 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
6.2 Infectious Disease Point of Care Diagnostics Key Players in North America (2019-2020)
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
7.2 Infectious Disease Point of Care Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
8 CHINA
8.1 China Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
8.2 Infectious Disease Point of Care Diagnostics Key Players in China (2019-2020)
8.3 China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
8.4 China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
9.2 Infectious Disease Point of Care Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
9.4 Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
10.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
11 INDIA
11.1 India Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
11.2 Infectious Disease Point of Care Diagnostics Key Players in India (2019-2020)
11.3 India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
11.4 India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
12.2 Infectious Disease Point of Care Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
13.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Siemens
13.2.1 Siemens Company Details
13.2.2 Siemens Business Overview and Its Total Revenue
13.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
13.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.2.5 Siemens Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview and Its Total Revenue
13.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
13.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Accriva
13.4.1 Accriva Company Details
13.4.2 Accriva Business Overview and Its Total Revenue
13.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
13.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.4.5 Accriva Recent Development
13.5 Terumo
13.5.1 Terumo Company Details
13.5.2 Terumo Business Overview and Its Total Revenue
13.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
13.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.5.5 Terumo Recent Development
13.6 BioMerieux
13.6.1 BioMerieux Company Details
13.6.2 BioMerieux Business Overview and Its Total Revenue
13.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
13.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.6.5 BioMerieux Recent Development
13.7 Diasorin
13.7.1 Diasorin Company Details
13.7.2 Diasorin Business Overview and Its Total Revenue
13.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
13.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.7.5 Diasorin Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview and Its Total Revenue
13.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
13.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Danaher Corporation
13.9.1 Danaher Corporation Company Details
13.9.2 Danaher Corporation Business Overview and Its Total Revenue
13.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
13.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.9.5 Danaher Corporation Recent Development
13.10 BD
13.10.1 BD Company Details
13.10.2 BD Business Overview and Its Total Revenue
13.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
13.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.10.5 BD Recent Development
13.11 Bio-Rad Laboratories
10.11.1 Bio-Rad Laboratories Company Details
10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
10.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
10.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.11.5 Bio-Rad Laboratories Recent Development
13.12 Cavidi
10.12.1 Cavidi Company Details
10.12.2 Cavidi Business Overview and Its Total Revenue
10.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
10.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.12.5 Cavidi Recent Development
13.13 Cepheid
10.13.1 Cepheid Company Details
10.13.2 Cepheid Business Overview and Its Total Revenue
10.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
10.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.13.5 Cepheid Recent Development
13.14 Diaxonhit
10.14.1 Diaxonhit Company Details
10.14.2 Diaxonhit Business Overview and Its Total Revenue
10.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
10.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.14.5 Diaxonhit Recent Development
13.15 Eiken Chemical
10.15.1 Eiken Chemical Company Details
10.15.2 Eiken Chemical Business Overview and Its Total Revenue
10.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
10.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.15.5 Eiken Chemical Recent Development
13.16 EMD Millipore
10.16.1 EMD Millipore Company Details
10.16.2 EMD Millipore Business Overview and Its Total Revenue
10.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
10.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.16.5 EMD Millipore Recent Development
13.17 Epitope Diagnostic
10.17.1 Epitope Diagnostic Company Details
10.17.2 Epitope Diagnostic Business Overview and Its Total Revenue
10.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
10.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.17.5 Epitope Diagnostic Recent Development
13.18 Euroimmun
10.18.1 Euroimmun Company Details
10.18.2 Euroimmun Business Overview and Its Total Revenue
10.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
10.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.18.5 Euroimmun Recent Development
13.19 Gold Standard Diagnostics
10.19.1 Gold Standard Diagnostics Company Details
10.19.2 Gold Standard Diagnostics Business Overview and Its Total Revenue
10.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
10.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.19.5 Gold Standard Diagnostics Recent Development
13.20 Hologic
10.20.1 Hologic Company Details
10.20.2 Hologic Business Overview and Its Total Revenue
10.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
10.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.20.5 Hologic Recent Development
13.21 Immunetics
10.21.1 Immunetics Company Details
10.21.2 Immunetics Business Overview and Its Total Revenue
10.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
10.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.21.5 Immunetics Recent Development
13.22 InBios International
10.22.1 InBios International Company Details
10.22.2 InBios International Business Overview and Its Total Revenue
10.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
10.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.22.5 InBios International Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
1.4 Market Analysis by Type
1.4.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Over-the-counter (OTC) Testing Kits
1.4.3 Prescription-based Testing Kits
1.5 Market by Application
1.5.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Bacterial Infections
1.5.3 Fungal Infection
1.5.4 Virus Infection
1.5.5 Cardiovascular Infection
1.5.6 Gastrointestinal Infection
1.5.7 Sexually Transmitted Disease (STD) Infection
1.5.8 Central Nervous System Infection
1.5.9 Other
1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Point of Care Diagnostics Industry Impact
1.6.1 How the Covid-19 is Affecting the Infectious Disease Point of Care Diagnostics Industry
1.6.1.1 Infectious Disease Point of Care Diagnostics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Infectious Disease Point of Care Diagnostics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Infectious Disease Point of Care Diagnostics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Infectious Disease Point of Care Diagnostics Market Perspective (2015-2026)
2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions
2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infectious Disease Point of Care Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Infectious Disease Point of Care Diagnostics Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Market Size
3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
3.2.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2019
3.3 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
3.4 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
3.5 Date of Enter into Infectious Disease Point of Care Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2021-2026)
5 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
6.2 Infectious Disease Point of Care Diagnostics Key Players in North America (2019-2020)
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
7.2 Infectious Disease Point of Care Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
8 CHINA
8.1 China Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
8.2 Infectious Disease Point of Care Diagnostics Key Players in China (2019-2020)
8.3 China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
8.4 China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
9.2 Infectious Disease Point of Care Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
9.4 Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
10.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
11 INDIA
11.1 India Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
11.2 Infectious Disease Point of Care Diagnostics Key Players in India (2019-2020)
11.3 India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
11.4 India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
12.2 Infectious Disease Point of Care Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
13.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Siemens
13.2.1 Siemens Company Details
13.2.2 Siemens Business Overview and Its Total Revenue
13.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
13.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.2.5 Siemens Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview and Its Total Revenue
13.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
13.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Accriva
13.4.1 Accriva Company Details
13.4.2 Accriva Business Overview and Its Total Revenue
13.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
13.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.4.5 Accriva Recent Development
13.5 Terumo
13.5.1 Terumo Company Details
13.5.2 Terumo Business Overview and Its Total Revenue
13.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
13.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.5.5 Terumo Recent Development
13.6 BioMerieux
13.6.1 BioMerieux Company Details
13.6.2 BioMerieux Business Overview and Its Total Revenue
13.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
13.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.6.5 BioMerieux Recent Development
13.7 Diasorin
13.7.1 Diasorin Company Details
13.7.2 Diasorin Business Overview and Its Total Revenue
13.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
13.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.7.5 Diasorin Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview and Its Total Revenue
13.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
13.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Danaher Corporation
13.9.1 Danaher Corporation Company Details
13.9.2 Danaher Corporation Business Overview and Its Total Revenue
13.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
13.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.9.5 Danaher Corporation Recent Development
13.10 BD
13.10.1 BD Company Details
13.10.2 BD Business Overview and Its Total Revenue
13.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
13.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.10.5 BD Recent Development
13.11 Bio-Rad Laboratories
10.11.1 Bio-Rad Laboratories Company Details
10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
10.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
10.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.11.5 Bio-Rad Laboratories Recent Development
13.12 Cavidi
10.12.1 Cavidi Company Details
10.12.2 Cavidi Business Overview and Its Total Revenue
10.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
10.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.12.5 Cavidi Recent Development
13.13 Cepheid
10.13.1 Cepheid Company Details
10.13.2 Cepheid Business Overview and Its Total Revenue
10.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
10.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.13.5 Cepheid Recent Development
13.14 Diaxonhit
10.14.1 Diaxonhit Company Details
10.14.2 Diaxonhit Business Overview and Its Total Revenue
10.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
10.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.14.5 Diaxonhit Recent Development
13.15 Eiken Chemical
10.15.1 Eiken Chemical Company Details
10.15.2 Eiken Chemical Business Overview and Its Total Revenue
10.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
10.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.15.5 Eiken Chemical Recent Development
13.16 EMD Millipore
10.16.1 EMD Millipore Company Details
10.16.2 EMD Millipore Business Overview and Its Total Revenue
10.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
10.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.16.5 EMD Millipore Recent Development
13.17 Epitope Diagnostic
10.17.1 Epitope Diagnostic Company Details
10.17.2 Epitope Diagnostic Business Overview and Its Total Revenue
10.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
10.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.17.5 Epitope Diagnostic Recent Development
13.18 Euroimmun
10.18.1 Euroimmun Company Details
10.18.2 Euroimmun Business Overview and Its Total Revenue
10.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
10.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.18.5 Euroimmun Recent Development
13.19 Gold Standard Diagnostics
10.19.1 Gold Standard Diagnostics Company Details
10.19.2 Gold Standard Diagnostics Business Overview and Its Total Revenue
10.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
10.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.19.5 Gold Standard Diagnostics Recent Development
13.20 Hologic
10.20.1 Hologic Company Details
10.20.2 Hologic Business Overview and Its Total Revenue
10.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
10.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.20.5 Hologic Recent Development
13.21 Immunetics
10.21.1 Immunetics Company Details
10.21.2 Immunetics Business Overview and Its Total Revenue
10.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
10.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.21.5 Immunetics Recent Development
13.22 InBios International
10.22.1 InBios International Company Details
10.22.2 InBios International Business Overview and Its Total Revenue
10.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
10.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.22.5 InBios International Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Infectious Disease Point of Care Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
Table 3. Ranking of Global Top Infectious Disease Point of Care Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Over-the-counter (OTC) Testing Kits
Table 6. Key Players of Prescription-based Testing Kits
Table 7. COVID-19 Impact Global Market: (Four Infectious Disease Point of Care Diagnostics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Infectious Disease Point of Care Diagnostics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Infectious Disease Point of Care Diagnostics Players to Combat Covid-19 Impact
Table 12. Global Infectious Disease Point of Care Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2015-2020)
Table 16. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Infectious Disease Point of Care Diagnostics Market Growth Strategy
Table 22. Main Points Interviewed from Key Infectious Disease Point of Care Diagnostics Players
Table 23. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Infectious Disease Point of Care Diagnostics Market Share by Players (2015-2020)
Table 25. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019)
Table 26. Global Infectious Disease Point of Care Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
Table 29. Date of Enter into Infectious Disease Point of Care Diagnostics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Infectious Disease Point of Care Diagnostics Market Size Share by Type (2015-2020)
Table 33. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2021-2026)
Table 34. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2015-2020)
Table 35. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 39. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 41. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 43. Europe Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 45. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 47. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 49. China Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 51. China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 52. China Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 53. China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 54. China Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 55. Japan Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 57. Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 59. Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 63. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 65. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 67. India Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 69. India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 70. India Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 71. India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 72. India Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 75. Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 77. Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Product
Table 82. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 83. Abbott Recent Development
Table 84. Siemens Company Details
Table 85. Siemens Business Overview
Table 86. Siemens Product
Table 87. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 88. Siemens Recent Development
Table 89. GE Healthcare Company Details
Table 90. GE Healthcare Business Overview
Table 91. GE Healthcare Product
Table 92. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 93. GE Healthcare Recent Development
Table 94. Accriva Company Details
Table 95. Accriva Business Overview
Table 96. Accriva Product
Table 97. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 98. Accriva Recent Development
Table 99. Terumo Company Details
Table 100. Terumo Business Overview
Table 101. Terumo Product
Table 102. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 103. Terumo Recent Development
Table 104. BioMerieux Company Details
Table 105. BioMerieux Business Overview
Table 106. BioMerieux Product
Table 107. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 108. BioMerieux Recent Development
Table 109. Diasorin Company Details
Table 110. Diasorin Business Overview
Table 111. Diasorin Product
Table 112. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 113. Diasorin Recent Development
Table 114. Roche Business Overview
Table 115. Roche Product
Table 116. Roche Company Details
Table 117. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 118. Roche Recent Development
Table 119. Danaher Corporation Company Details
Table 120. Danaher Corporation Business Overview
Table 121. Danaher Corporation Product
Table 122. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 123. Danaher Corporation Recent Development
Table 124. BD Company Details
Table 125. BD Business Overview
Table 126. BD Product
Table 127. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 128. BD Recent Development
Table 129. Bio-Rad Laboratories Company Details
Table 130. Bio-Rad Laboratories Business Overview
Table 131. Bio-Rad Laboratories Product
Table 132. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 133. Bio-Rad Laboratories Recent Development
Table 134. Cavidi Company Details
Table 135. Cavidi Business Overview
Table 136. Cavidi Product
Table 137. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 138. Cavidi Recent Development
Table 139. Cepheid Company Details
Table 140. Cepheid Business Overview
Table 141. Cepheid Product
Table 142. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 143. Cepheid Recent Development
Table 144. Diaxonhit Company Details
Table 145. Diaxonhit Business Overview
Table 146. Diaxonhit Product
Table 147. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 148. Diaxonhit Recent Development
Table 149. Eiken Chemical Company Details
Table 150. Eiken Chemical Business Overview
Table 151. Eiken Chemical Product
Table 152. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 153. Eiken Chemical Recent Development
Table 154. EMD Millipore Company Details
Table 155. EMD Millipore Business Overview
Table 156. EMD Millipore Product
Table 157. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 158. EMD Millipore Recent Development
Table 159. Epitope Diagnostic Company Details
Table 160. Epitope Diagnostic Business Overview
Table 161. Epitope Diagnostic Product
Table 162. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 163. Epitope Diagnostic Recent Development
Table 164. Euroimmun Company Details
Table 165. Euroimmun Business Overview
Table 166. Euroimmun Product
Table 167. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 168. Euroimmun Recent Development
Table 169. Gold Standard Diagnostics Company Details
Table 170. Gold Standard Diagnostics Business Overview
Table 171. Gold Standard Diagnostics Product
Table 172. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 173. Gold Standard Diagnostics Recent Development
Table 174. Hologic Company Details
Table 175. Hologic Business Overview
Table 176. Hologic Product
Table 177. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 178. Hologic Recent Development
Table 179. Immunetics Company Details
Table 180. Immunetics Business Overview
Table 181. Immunetics Product
Table 182. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 183. Immunetics Recent Development
Table 184. InBios International Company Details
Table 185. InBios International Business Overview
Table 186. InBios International Product
Table 187. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 188. InBios International Recent Development
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
Table 1. Infectious Disease Point of Care Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
Table 3. Ranking of Global Top Infectious Disease Point of Care Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Over-the-counter (OTC) Testing Kits
Table 6. Key Players of Prescription-based Testing Kits
Table 7. COVID-19 Impact Global Market: (Four Infectious Disease Point of Care Diagnostics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Infectious Disease Point of Care Diagnostics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Infectious Disease Point of Care Diagnostics Players to Combat Covid-19 Impact
Table 12. Global Infectious Disease Point of Care Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2015-2020)
Table 16. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Infectious Disease Point of Care Diagnostics Market Growth Strategy
Table 22. Main Points Interviewed from Key Infectious Disease Point of Care Diagnostics Players
Table 23. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Infectious Disease Point of Care Diagnostics Market Share by Players (2015-2020)
Table 25. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019)
Table 26. Global Infectious Disease Point of Care Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
Table 29. Date of Enter into Infectious Disease Point of Care Diagnostics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Infectious Disease Point of Care Diagnostics Market Size Share by Type (2015-2020)
Table 33. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2021-2026)
Table 34. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2015-2020)
Table 35. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 39. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 41. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 43. Europe Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 45. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 47. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 49. China Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 51. China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 52. China Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 53. China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 54. China Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 55. Japan Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 57. Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 59. Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 63. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 65. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 67. India Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 69. India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 70. India Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 71. India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 72. India Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 75. Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 77. Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Product
Table 82. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 83. Abbott Recent Development
Table 84. Siemens Company Details
Table 85. Siemens Business Overview
Table 86. Siemens Product
Table 87. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 88. Siemens Recent Development
Table 89. GE Healthcare Company Details
Table 90. GE Healthcare Business Overview
Table 91. GE Healthcare Product
Table 92. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 93. GE Healthcare Recent Development
Table 94. Accriva Company Details
Table 95. Accriva Business Overview
Table 96. Accriva Product
Table 97. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 98. Accriva Recent Development
Table 99. Terumo Company Details
Table 100. Terumo Business Overview
Table 101. Terumo Product
Table 102. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 103. Terumo Recent Development
Table 104. BioMerieux Company Details
Table 105. BioMerieux Business Overview
Table 106. BioMerieux Product
Table 107. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 108. BioMerieux Recent Development
Table 109. Diasorin Company Details
Table 110. Diasorin Business Overview
Table 111. Diasorin Product
Table 112. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 113. Diasorin Recent Development
Table 114. Roche Business Overview
Table 115. Roche Product
Table 116. Roche Company Details
Table 117. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 118. Roche Recent Development
Table 119. Danaher Corporation Company Details
Table 120. Danaher Corporation Business Overview
Table 121. Danaher Corporation Product
Table 122. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 123. Danaher Corporation Recent Development
Table 124. BD Company Details
Table 125. BD Business Overview
Table 126. BD Product
Table 127. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 128. BD Recent Development
Table 129. Bio-Rad Laboratories Company Details
Table 130. Bio-Rad Laboratories Business Overview
Table 131. Bio-Rad Laboratories Product
Table 132. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 133. Bio-Rad Laboratories Recent Development
Table 134. Cavidi Company Details
Table 135. Cavidi Business Overview
Table 136. Cavidi Product
Table 137. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 138. Cavidi Recent Development
Table 139. Cepheid Company Details
Table 140. Cepheid Business Overview
Table 141. Cepheid Product
Table 142. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 143. Cepheid Recent Development
Table 144. Diaxonhit Company Details
Table 145. Diaxonhit Business Overview
Table 146. Diaxonhit Product
Table 147. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 148. Diaxonhit Recent Development
Table 149. Eiken Chemical Company Details
Table 150. Eiken Chemical Business Overview
Table 151. Eiken Chemical Product
Table 152. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 153. Eiken Chemical Recent Development
Table 154. EMD Millipore Company Details
Table 155. EMD Millipore Business Overview
Table 156. EMD Millipore Product
Table 157. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 158. EMD Millipore Recent Development
Table 159. Epitope Diagnostic Company Details
Table 160. Epitope Diagnostic Business Overview
Table 161. Epitope Diagnostic Product
Table 162. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 163. Epitope Diagnostic Recent Development
Table 164. Euroimmun Company Details
Table 165. Euroimmun Business Overview
Table 166. Euroimmun Product
Table 167. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 168. Euroimmun Recent Development
Table 169. Gold Standard Diagnostics Company Details
Table 170. Gold Standard Diagnostics Business Overview
Table 171. Gold Standard Diagnostics Product
Table 172. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 173. Gold Standard Diagnostics Recent Development
Table 174. Hologic Company Details
Table 175. Hologic Business Overview
Table 176. Hologic Product
Table 177. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 178. Hologic Recent Development
Table 179. Immunetics Company Details
Table 180. Immunetics Business Overview
Table 181. Immunetics Product
Table 182. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 183. Immunetics Recent Development
Table 184. InBios International Company Details
Table 185. InBios International Business Overview
Table 186. InBios International Product
Table 187. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 188. InBios International Recent Development
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Over-the-counter (OTC) Testing Kits Features
Figure 3. Prescription-based Testing Kits Features
Figure 4. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Bacterial Infections Case Studies
Figure 6. Fungal Infection Case Studies
Figure 7. Virus Infection Case Studies
Figure 8. Cardiovascular Infection Case Studies
Figure 9. Gastrointestinal Infection Case Studies
Figure 10. Sexually Transmitted Disease (STD) Infection Case Studies
Figure 11. Central Nervous System Infection Case Studies
Figure 12. Other Case Studies
Figure 13. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 14. Global Infectious Disease Point of Care Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Infectious Disease Point of Care Diagnostics Market Share by Regions: 2020 VS 2026
Figure 16. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2019
Figure 19. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2019
Figure 21. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 30. Siemens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 32. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 34. Accriva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 36. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 38. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 40. Diasorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 42. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 44. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 46. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 48. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 50. Cavidi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 52. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 54. Diaxonhit Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 56. Eiken Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 58. EMD Millipore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 60. Epitope Diagnostic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 62. Euroimmun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 64. Gold Standard Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 66. Hologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Figure 1. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Over-the-counter (OTC) Testing Kits Features
Figure 3. Prescription-based Testing Kits Features
Figure 4. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Bacterial Infections Case Studies
Figure 6. Fungal Infection Case Studies
Figure 7. Virus Infection Case Studies
Figure 8. Cardiovascular Infection Case Studies
Figure 9. Gastrointestinal Infection Case Studies
Figure 10. Sexually Transmitted Disease (STD) Infection Case Studies
Figure 11. Central Nervous System Infection Case Studies
Figure 12. Other Case Studies
Figure 13. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 14. Global Infectious Disease Point of Care Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Infectious Disease Point of Care Diagnostics Market Share by Regions: 2020 VS 2026
Figure 16. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2019
Figure 19. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2019
Figure 21. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 30. Siemens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 32. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 34. Accriva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 36. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 38. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 40. Diasorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 42. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 44. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 46. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 48. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 50. Cavidi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 52. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 54. Diaxonhit Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 56. Eiken Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 58. EMD Millipore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 60. Epitope Diagnostic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 62. Euroimmun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 64. Gold Standard Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 66. Hologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed